Άρθρα: Εργασίες Ελλήνων ιατρών

Εργασίες Ελλήνων ιατρών

30/4/2020

Wilson disease: 30-year data on epidemiology, clinical presentation, treatment modalities and disease outcomes from two tertiary Greek centers

Maria Tampaki, Nikolaos K. Gatselis, Spyridon Savvanis, Emmanouil Koullias, Asterios Saitis, Stella Gabeta, Melanie Deutsch, Emmanouil Manesis, Georgios N. Dalekos and John Koskinas

περισσότερα...

27/4/2020

Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma

Maria Tampaki, Evangelos Ionas, Emilia Hadziyannis , Melanie Deutsch , Katerina Malagari and John Koskinas

περισσότερα...

22/4/2020

Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B

Emilia Hadziyannis and Stephanos Hadziyannis

περισσότερα...

22/4/2020

NAFLD and autoimmune hepatitis: Do not judge a book by its cover

George N. Dalekos, Nikolaos K. Gatselis, Kalliopi Zachou, George K. Koukoulis

περισσότερα...

10/4/2020

Validating and expanding the Baveno VI criteria for esophageal varices in patients with advanced liver disease: a multicenter study

Adonis A. Protopapas, Theodora Mylopoulou, Vasileios P. Papadopoulos, Kiriaki Vogiatzi, Ioannis Goulis, Konstantinos Mimidis

περισσότερα...

3/3/2020

Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B

περισσότερα...

26/2/2020

NAFLD and autoimmune hepatitis: Do not judge a book by its cover

George N. Dalekos, Nikolaos K. Gatselis,Kalliopi Zachou, George K. Koukoulis

περισσότερα...

26/2/2020

Factors Associated With Progression and Outcomes of Early Stage Primary Biliary Cholangitis

Patients usually receive a diagnosis of primary biliary cholangitis (PBC) at an early stage, based on biochemical analyses. We investigated the proportion of patients who progress to moderate or advanced PBC and factors associated with progression and patient survival.

περισσότερα...

14/1/2019

Hellenic Association for the Study of the Liver Clinical Practice Guidelines: Autoimmune hepatitis

George N. Dalekos, John Koskinas, George V. Papatheodoridis Institute of Internal Medicine and Hepatology, Larissa; University Hospital of Larissa; National and Kapodistrian University of Athens, “Hippokratio” General Hospital of Athens, Athens; Medical School of National and Kapodistrian University of Athens, “Laiko” General Hospital of Athens, Athens, Greece

περισσότερα...

17/4/2018

The British Society of Gastroenterology/UKPBC primary biliary cholangitis treatment and management guidelines

Gideon M Hirschfield,Jessica K Dyson, Graeme J M Alexander, Michael H Chapman, Jane Collier, Stefan Hübscher, Imran Patanwala, Stephen P Pereira, Collette Thain, Douglas Thorburn, Dina Tiniakos, Martine Walmsley, George Webster, David E J Jones

περισσότερα...

3/10/2017

Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis

Increased cholestatic enzymes in two patients with long-term history of ulcerative colitis: consider primary biliary cholangitis not always primary sclerosing cholangitis Erietta Polychronopoulou, Vasiliki Lygoura, Nikolaos K Gatselis, George N Dalekos

περισσότερα...

7/7/2017

Geoepidemiology, clinical manifestations and outcome of primary biliary cholangitis in Greece

Nikolaos K. Gatselis, Kalliopi Zachou, Vasiliki Lygoura, Kalliopi Azariadis, Pinelopi Arvaniti, Elias Spyrou, Georgia Papadamou, George K. Koukoulis, George N. Dalekos, Eirini I. Rigopoulou

περισσότερα...

16/12/2016

Efficacy of prophylactic antiviral therapy and outcomes in HBsAg-negative, anti-HBc-positive patients receiving chemotherapy: a real-life experience

Nikolaos Papadopoulosa, Melanie Deutschc, Spilios Manolakopoulosc, Chrysoula Bitsia, Helias Michalakeasb,Helias Poulakidasb, Eftychia Tsironie, Stavroula Giannoulic, George V. Papatheodoridisd, John Koskinasc and Dimitrios Pectasides

περισσότερα...

17/10/2016

Severe liver involvement in two patients with long-term history of fever : remember familial Mediterranean fever

περισσότερα...

30/9/2016

Molecular diagnostic testing for primary biliary cholangitis.

περισσότερα...

30/9/2016

von Willebrand factor and procoagulant imbalance independently predict outcome in patients with cirrhosis and thrombocytopenia.

περισσότερα...

30/9/2016

Reliability and applicability of two-dimensional shear-wave elastography for the evaluation of liver stiffness.

περισσότερα...

30/9/2016

Is elimination of HCV possible in a country with low diagnostic rate and moderate HCV prevalence? The case of Greece

περισσότερα...

30/9/2016

Evaluation of neutrophil/leukocyte ratio and organ failure score as predictors of reversibility and survival following an acute-on-chronic liver failure event

περισσότερα...

30/9/2016

Discontinuation of oral antivirals in chronic hepatitis B: A systematic review

περισσότερα...

30/9/2016

Extensively drug-resistant bacteria are an independent predictive factor of mortality in 130 patients with spontaneous bacterial peritonitis or spontaneous bacteremia

περισσότερα...

30/9/2016

TGF-β signaling is activated in patients with chronic HBV infection and repressed by SMAD7 overexpression after successful antiviral treatment

περισσότερα...

30/9/2016

Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency

περισσότερα...

30/9/2016

Circulating adiponectin levels in type 2 diabetes mellitus patients with or without non-alcoholic fatty liver disease: Results of a small, open-label, randomized controlled intervention trial in a subgroup receiving short-term exenatide

περισσότερα...

28/3/2016

PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy

περισσότερα...

28/3/2016

A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis

περισσότερα...

3/2/2014

Autoimmune hepatitis – current management and challenges

Autoimmune hepatitis remains a major diagnostic and therapeutic challenge. The clinician, the hepato-pathologist and the laboratory personnel need to become more familiar with different expressions of the disease, interpretation of liver histology and autoimmune serology.

περισσότερα...

Ημερολόγιο

Κατηγορίες

Search Location